Financial release accessible
online
BOSTON, May 9, 2024
/PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that
financial results for its fourth quarter and fiscal year 2024,
which ended March 30, 2024, are
available on its Investor Relations website.
The Company will host a conference call and webcast with
investors and analysts to discuss and answer questions about the
results at 8:00 a.m. ET on
May 9, 2024. The conference call and
webcast can be accessed with the following information:
- Teleconference link:
https://register.vevent.com/register/BI7654787bc47144b39cb181c1abab0531
- Once registration is completed, participants will receive a
dial-in number along with a personalized PIN to access the call.
While not required, it is recommended that participants join 10
minutes prior to the event start.
- A live webcast of the call can be accessed on
Haemonetics' investor relations website or via
the following link:
https://edge.media-server.com/mmc/p/5cppxurr
In addition, the Company has posted to its Investor Relations
website the earnings release and certain supplemental analytical
tables including two years of historical revenue information recast
in the updated revenue reporting structure that will be referenced
on its conference call and webcast, links to which are available
below.
Direct link to 4Q FY24 Earnings Release:
https://haemonetics.gcs-web.com/static-files/4c58f1e8-c0ed-46e7-89b4-99a6d4dc53c6
Direct link to Service Revenue Reporting Change Analytical
Tables:
https://haemonetics.gcs-web.com/static-files/e6895d75-dd6f-4f9f-af30-387bd364b386
A replay of the conference call and webcast will be available
for one year beginning on May 9,
2024, at 11:00 a.m. ET using
the conference call webcast link provided in this press
release.
About Haemonetics
Haemonetics (NYSE: HAE) is a global
healthcare company dedicated to providing a suite of innovative
medical products and solutions for customers, to help them improve
patient care and reduce the cost of healthcare. Our technology
addresses important medical markets: blood and plasma component
collection, the surgical suite and hospital transfusion services.
To learn more about Haemonetics, visit www.haemonetics.com.
Investor Contacts:
Olga Guyette, Sr. Director-Investor
Relations & Treasury
(781) 356-9763
olga.guyette@haemonetics.com
David Trenk, Manager-Investor
Relations
(203) 733-4987
david.trenk@haemonetics.com
Media Contact:
Josh Gitelson, Director-Global
Communications
(781) 356-9776
josh.gitelson@haemonetics.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/haemonetics-4th-quarter-and-fiscal-year-2024-earnings-release-available-on-investor-relations-website-302140225.html
SOURCE Haemonetics Corporation